Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
+6.36%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$5.75B
AUM Growth
+$430M
(+8.1%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-18.82%
Top 10 Holdings %
Top 10 Hldgs %
27.15%
Holding
1,587
New
76
Increased
379
Reduced
937
Closed
183
Top Buys
| 1 |
HP
HPQ
|
+$6.72M |
| 2 |
Newmont
NEM
|
+$6.32M |
| 3 |
General Mills
GIS
|
+$6.24M |
| 4 |
TJX Companies
TJX
|
+$5.82M |
| 5 |
Ford
F
|
+$5.76M |
Top Sells
| 1 |
Iron Mountain
IRM
|
+$16.2M |
| 2 |
Apple
AAPL
|
+$15.9M |
| 3 |
Amazon
AMZN
|
+$14.5M |
| 4 |
Microsoft
MSFT
|
+$13.1M |
| 5 |
GDS Holdings
GDS
|
+$7.93M |
Sector Composition
| 1 | Real Estate | 17.47% |
| 2 | Technology | 14.61% |
| 3 | Consumer Discretionary | 9.29% |
| 4 | Healthcare | 7.36% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
ImmunityBio
IBRX
$2.45B
| $38K | ﹤0.01% |
+1,618
| New | +$38K |
|
1327
Sibanye-Stillwater
SBSW
$6.18B
| $38K | ﹤0.01% |
2,119
+846
| +66% | +$15.2K |
|
1328
Passage Bio
PASG
$22.4M
| $37K | ﹤0.01% |
+106
| New | +$37K |
|
|
MANT
1329
DELISTED
Mantech International Corp
MANT
| $36K | ﹤0.01% |
410
+15
| +4% | +$1.32K |
|
|
PBFX
1330
DELISTED
PBF LOGISTICS LP
PBFX
| $35K | ﹤0.01% |
2,395
+9
| +0.4% | +$132 |
|
1331
Gerdau
GGB
$6.17B
| $31K | ﹤0.01% |
7,334
+2,797
| +62% | +$11.8K |
|
1332
Kornit Digital
KRNT
$662M
| $31K | ﹤0.01% |
310
-15
| -5% | -$1.5K |
|
1333
Avidity Biosciences
RNA
$5.97B
| $31K | ﹤0.01% |
1,417
+578
| +69% | +$12.6K |
|
1334
Stoke Therapeutics
STOK
$1.31B
| $31K | ﹤0.01% |
811
+384
| +90% | +$14.7K |
|
1335
V2X
VVX
$1.73B
| $31K | ﹤0.01% |
587
-54
| -8% | -$2.85K |
|
1336
Akero Therapeutics
AKRO
$3.59B
| $30K | ﹤0.01% |
1,034
-216
| -17% | -$6.27K |
|
1337
BRF SA
BRFS
$5.99B
| $29K | ﹤0.01% |
6,348
+2,436
| +62% | +$11.1K |
|
1338
CytomX Therapeutics
CTMX
$341M
| $29K | ﹤0.01% |
3,806
+1,000
| +36% | +$7.62K |
|
1339
Fiverr
FVRR
$858M
| $29K | ﹤0.01% |
135
-5
| -4% | -$1.07K |
|
1340
Geron
GERN
$842M
| $29K | ﹤0.01% |
18,114
+3,236
| +22% | +$5.18K |
|
1341
Praxis Precision Medicines
PRAX
$847M
| $29K | ﹤0.01% |
+58
| New | +$29K |
|
|
TECX
1342
Tectonic Therapeutic, Inc. Common Stock
TECX
$324M
| $29K | ﹤0.01% |
193
+93
| +93% | +$14K |
|
|
CMRX
1343
DELISTED
Chimerix, Inc.
CMRX
| $29K | ﹤0.01% |
+2,996
| New | +$29K |
|
1344
Kiniksa Pharmaceuticals
KNSA
$2.68B
| $28K | ﹤0.01% |
1,503
-870
| -37% | -$16.2K |
|
1345
Puma Biotechnology
PBYI
$229M
| $28K | ﹤0.01% |
2,837
-598
| -17% | -$5.9K |
|
1346
TIM SA
TIMB
$10B
| $28K | ﹤0.01% |
2,491
+950
| +62% | +$10.7K |
|
1347
Anika Therapeutics
ANIK
$121M
| $26K | ﹤0.01% |
645
+40
| +7% | +$1.61K |
|
1348
Ardelyx
ARDX
$1.6B
| $26K | ﹤0.01% |
3,896
+1,562
| +67% | +$10.4K |
|
1349
Arcutis Biotherapeutics
ARQT
$2.11B
| $26K | ﹤0.01% |
887
-184
| -17% | -$5.39K |
|
|
ATHX
1350
DELISTED
Athersys, Inc. Common Stock
ATHX
| $26K | ﹤0.01% |
576
+70
| +14% | +$3.16K |
|